- In April 2024, Lexogen, a biotech firm specializing in RNA research, introduced new solutions specifically designed for transcriptome profiling of formalin-fixed paraffin-embedded (FFPE) samples. These "biobank" samples are invaluable for researchers in fields such as cancer research, drug discovery, and development
- In March 2024, Insilico Medicine ("Insilico") launched the PandaOmics Box, a hardware platform designed for data privacy and security in biological analytics. PandaOmics Box operates without Internet access, enabling on-premise target identification, biomarker discovery, indication prioritization, and advanced research in personalized medicine and drug discovery
- In March 2024, 10x Genomics, Inc., a leader in single-cell and spatial biology, announced the commercial release of its Visium HD Spatial Gene Expression assay. This product allows researchers to measure the whole transcriptome from FFPE tissue sections at single-cell resolution
- In February 2024, NanoString Technologies, Inc., a leader in life science research tools, launched the CosMx Human 6K Discovery Panel. This single-cell spatial panel allows researchers to study over 6,000 RNA targets, covering nearly all human biological pathways. NanoString, along with independent researchers, also highlighted the product's whole transcriptome imaging capability at the Advances in Genome Biology and Technology (AGBT) General Meeting in Orlando, Florida, held from February 5-8
- In February 2023, Curio Bioscience launched commercial operations with the introduction of Curio Seeker, the world’s first high-resolution, whole-transcriptome spatial mapping kit. Based on the Slide-seq technique developed by its co-founders at the Broad Institute of MIT and Harvard, Curio Seeker enables labs to create whole-transcriptome spatial data from tissue samples through an easy-to-use workflow
Frequently Asked Questions
The market is segmented based on Segmentation, By Product and Services (Instruments, Consumables, Software, and Services), Technology (Microarray, Real Time-PCR (qPCR), and Sequencing), Application (Diagnostics and Disease Profiling, Drug Discovery, and Others), End User (Pharmaceutical and Biotechnology Companies, Government Institutes and Academic Centers, and Contract Research Organizations (CROs)) – Industry Trends and Forecast to 2031
.
The Global Transcriptomics Market size was valued at USD 7.64 USD Billion in 2023.
The Global Transcriptomics Market is projected to grow at a CAGR of 0% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
